In the October issue of On Drug Delivery, Richard Motruk and Nathan Blazei discuss the issues to be considered in light of the US FDA’s tightened reliability standards for emergency-use autoinjectors. Because autoinjectors are typically the delivery device of choice for emergency medications, they come with increased scrutiny from regulatory bodies regarding their safety and effectiveness.
